The Constitutional Court gave judgment in the matter between Dudley Lee and the Minister of Correctional Services on 11 December 2012. The court ruled in favour of Lee. Thus, yesterday almost marked the end of Mr Lee’s seven-year journey through three courts; the Cape High Court will still have to determine the amount the state must pay him.

The risk for hepatotoxicity among patients treated with anti-tuberculosis (TB) drugs is affected by gender, ethnicity, and the presence of genetic polymorphisms, say Argentinean researchers.

A recent study conducted by Connecticut and Georgia researchers found that the QuantiFERON-TB Gold assay led to fewer false positives for tuberculosis than the tuberculin skin test.

A leading doctor has warned that Britain will be ‘swamped’ by tuberculosis unless new measures to diagnose the disease in immigrants are introduced.

UNITAID had made new grants to allow hundreds of thousands of children in developing countries to access better and more affordable medicines for HIV/AIDS, malaria and tuberculosis (TB).

On 4 December, the first meeting of the Regional Interagency Collaborative Committee on TB care and control (RICC-TB) took place in Copenhagen. The TB Europe Coalition had been pushing for the creation of this oversight mechanism for the past few years to make sure a stronger commitment be made in the fight against drug-resistant TB in the European region.

State Budget of Ukraine for 2013, voted on today by the Verkhovna Rada of Ukraine, became fatal sentence for 110,000 Ukrainians living with HIV, tuberculosis and hepatitis – it was reported today by the representatives of UCAB patient organization that fights for the treatment for people living with terminal diseases in Ukraine.

This World AIDS Day, global health pundits are again offering answers to the perennial questions: Can we, and when will we, eliminate HIV and its sibling plague, TB? The two pandemics are, after all, deeply intertwined: TB remains the leading cause of death for those infected with HIV. Advocates and activists have set their sights high. They want to "Get to Zero": zero new HIV infections, zero discrimination, zero AIDS related deaths; and, similarly, zero TB deaths, zero new TB infections, zero TB suffering. Not everyone thinks this is realistic. Many global health experts share the views expressed by Tom Paulson in a recent Humanosphere post titled, "Sorry, but no, the end of AIDS is not in sight."

The Operational Strategy outlines the Partnership Secretariat's four strategic priorities over the next three years.

Bedaquiline, the first agent in a new class of TB drug, has been recommended for accelerated approval by the Anti-Infective Drugs Advisory Committee of the United States Food and Drug Administration (FDA).